RE:RE:RE:RE:Latest nr Well that would certainly be an interesting turn of events. But the NR doesn't say that either. For 100%, pac west is also our partner for the beverage line that already has 2 X 500k unit POs (an initial with a follow up same customer) while the delta 8 just finished R&D so it actually makes more sense it would be for the beverage sku as there's already an order? Delta 8 or beverage makes no difference. The point still stands that it wasn't changing the Tabletz narrative where we already have an aprroved package design (and most likely a bunch of extra packages since you wouldn't just ship small batches of packaging from China lol. Regardless I'm glad you brought that up. Just highlighting another potential revenue stream. The beauty of our business model is it doesn't matter really matter too much if delta 8 has a lasting place in market or just a fad (besides the obvious fact that each product that succeeds and lasts long time means longer recurring revenues). It is our IP and ingredients not our branding. Revenue is revenue. If we produce /sell a bunch of delta 8 for a year or 2 and it fades out then we had delta 8 revenues (with no delta 8 specific costs) for a year or 2 lol. Really we just need this final execution. Ship the initial order and get a few more smoothly under our belts to show consistency and bibs your uncle.
sundial growers: not profitable / trading 7X sales
Canopy : not profitable / trading 20 x sales
Cronos : not profitable / trading 58 x sales
Tell me again how we aren't undervalued? Yes it isn't the best metric to showcase bloated overvalued pigs as a comparative , but in this case it isn't the worst . There are so many other examples with far too much forward thinking baked in to today's price. Yet here we sit with a decent chance of ending the year with $10-$14-$20+ million (even with all the annoying delays) . Wherever we fall it will be on good margins with no toxic debt, minimal overhead, and it will be 90%-95% from just a handful of orders for one deal in one country for one product (and only about 6 months of shipping). That description is the exact thing that justifies trading at multiples much higher than I've ever used for us. The reason is simply a combination of legitimacy and the existing room for explosive potential growth. If we do get let's say $10 mil revs this year (really more like 6 months) that wouldn't only be like 80x our highest ever sales (at good margins ) but it would also mean that just with those locations to date (by end of year) we should be able to double that in 2022 (12 months instead of 6 and allowing for no growth in sales or added locations/countries). Literally all that needs to happen now is execution and that our products are well received. IMO the risk/reward ratio here is something that doesn't come around every day. Frustrated yet confident . GLTUA